Global Spatial Genomics and Transcriptomics Market is Projected to Reach $2,173.0 Million

According to a new market intelligence report by BIS Research titled ‘Global Spatial Genomics and Transcriptomics Market − Analysis and Forecast, 2020-20230’, As per BIS Research analysis, the global spatial genomics and transcriptomics market is projected to reach $2,173.0 million by 2030 from $269.6 million in 2020, at a CAGR of 23.20% during the forecast period, 2020-2030.

BIS Research Report: https://bisresearch.com/industry-report/spatial-genomics-transcriptomics-market.html

Growth in this market is expected to be driven by the rising incidence of genetic disorders such as cancer and neurological disorders inciting the development of high-throughput diagnostics. This growing prevalence incites the development of rapid diagnostic assays, technological advancements in sequencing technology, and significant external funding for executing R&D exercise. However, there are significant challenges that are restraining the market growth, such as a shortage of computational analysis tools and high capital required for infrastructure and development of spatial technology-based solutions.

Request for Sample Report: https://bisresearch.com/requestsample?id=1018&type=download

The BIS Research report on the global spatial genomics and transcriptomics market segments the market on the basis of product type (kits and assays, instruments, software and services), application (diagnostics, translational research, drug discovery and development, single cell analysis, cell biology and others), end user (academic and research institutions, biopharmaceutical and biotechnological companies, contract research organizations and other end users), and region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World).

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

Comments

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: • Industry Analysis ...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases. COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...

Market Research Reports

Search This Blog